Legal entity
Faruqi & Faruqi, LLP is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across an 18-day span, the pace is roughly 0.8 stories per week. At 5, the average consequence score sits below the same-window beat average of 6.5.
Last mentioned: Mar 22, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Faruqi & Faruqi, LLP is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across an 18-day span, the pace is roughly 0.8 stories per week. At 5, the average consequence score sits below the same-window beat average of 6.5. They are better corroborated than the beat average, carrying 3 original sources each against 2.9 for the same window. Coverage clusters in corporate-law, which accounts for 1 of those 2, with the remainder spread across 1 other category. Enphase Energy appears in 2 tracked Legal stories published from March 5, 2026 through March 22, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 807 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Enphase Energy. Shared-story counts are live from our verified record — not editorial picks.
Enphase Energy (ENPH) Deadline
Final day for investors to move for lead plaintiff status in the ENPH securities class action.
Picard Medical (PMI) Deadline
Final day for investors to move for lead plaintiff status in the PMI securities class action.
Paysafe (PSFE) Deadline
Final day for investors to move for lead plaintiff status in the PSFE securities class action.
Enphase Suit Filed
Pomerantz LLP files class action litigation against Enphase Energy in federal court.
Litigation Launch
Pomerantz LLP officially announces class action litigation against Nektar Therapeutics.
Nektar Financial Update
Nektar files updated results of operations and financial condition reports.
Nektar Disclosure
Nektar Therapeutics issues Regulation FD disclosure regarding its business operations.
Enphase Financials
Enphase Energy files results of operations with the SEC, highlighting market challenges.
Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Source: pr-inside.com · pr-inside.com
Faruqi & Faruqi, LLP has issued critical lead plaintiff deadlines for securities class actions against Paysafe, Picard Medical, and Enphase Energy. Investors in these high-growth sectors have until April 2026 to join litigation alleging potential federal securities law violations.
Source: prnewswire.com · prnewswire.com
Enphase Energy is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
